Important Conference Call
To listen to the corporate update conference call of August 27, 2008 please use button bar below.
Latest Press Releases
Mymetics Corporation now Blue Sky registered in 44 States.
Nyon, Switzerland (September 23, 2008)
Mymetics Corporation (OTCBB: MYMX),announced today that its common stock has been Blue Sky registered for trading in 44 US States with fully compliant filings submitted and awaiting imminent approval for the remaining (MI, MO, MN, NC, ND, TX) states. [more]
Successful Results for Mymetics Corporation’s Mucosal HIV/AIDS vaccine ViralChallenge significantly exceeds expectations.
Nyon, Switzerland (September 16, 2008)
Mymetics Corporation (OTCBB: MYMX),a vaccine development company, is pleased to announce their preliminary SHIV challenge results on nonhuman primates previously immunized with the Company's mucosal HIV-AIDS vaccine designed for triggering mucosal protection. The results significantly exceed the Industry standard of 60% to 70% effectiveness to be considered as a promising vaccine as well as of Mymetics’ expectation which was considerably above this level. [more]
What makes Mymetics so innovative and promising?
Our original design - Prophylactics that combine innovative antigen engineering, minimal human protein homologies, and virosome technology.
Our pioneering approach - Vaccines that elicit protection for preventing early transmission events taking place within the first hours following exposure, such as the mucosal entry of pathogens. As a second line of defense, our vaccines elicit protection against later events as well.
Our "Best of Class" Network" –Support of reputable scientific partners and strategic alliances with both public and private institutions.
|
